175 results
Page 5 of 9
8-K
EX-99.1
eutqwtpt7gry 3bnnym
12 Nov 20
Agile Therapeutics Reports Third Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
cw7628yj06i7
11 Aug 20
Agile Therapeutics Reports Second Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
8l8v4jytycr i1kg1
5 May 20
Agile Therapeutics Reports First Quarter 2020 Financial Results
4:11pm
8-K
EX-99.1
n0gs7d1jisxdhl 18lk
26 Feb 20
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
mts1es9
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
8-K
EX-99.2
uilxwzvuft43tqa
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
8-K
EX-1.1
ojme3 o05
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
424B5
f789u
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
q1eu66r704pif4ug no
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
tujmlhfascz
20 Feb 20
Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
4:27pm
8-K
EX-99.1
k1shxr97zrwybnys9i
18 Feb 20
Regulation FD Disclosure
8:50am
8-K
EX-99.1
2mprqm kj4jb
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
qf9awfh9fc
12 Feb 20
Entry into a Material Definitive Agreement
8:00am